Prime Medicine, founded by David Liu, is finding that the path of translating scientific breakthroughs to treatments is ...

Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs ...

Opinion: “Exposed” by Wendy Kline shows how the pelvic exam exemplifies questions about gender, medicine, and power.

Stanford professor James Zou examined the clinical adoption of medical AI devices, and found that only a handful are being ...

The CDC said an investigation into a human H5N1 bird flu infection in Missouri has found four additional health care workers ...

WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, introduced a bill to let some small drugmakers avoid Medicare price ...

Top of the morning to you, and a fine one it is, despite the gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall ...

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

WASHINGTON — The wheels on a big red bus emblazoned with anti-pharmaceutical industry messaging are going ’round and ’round all through the nation’s electoral battlegrounds, from Montana ...

Dhillon is an instructor in the Division of Global Health Equity at Brigham and Women’s Hospital and Harvard Medical School.

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.